Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KRTL Holding Group is a holding company focused on strategic management and oversight of subsidiaries in the life sciences, pharmaceutical, and consulting sectors. Through its FDA-registered subsidiary KRTL Biotech Inc., it engages in R&D and facilitates cGMP manufacturing and compliance partnerships. KRTL International Inc. focuses on distribution and consulting. The group also holds a majority stake in Nutrivance Global for Active Pharmaceutical Ingredient (API) distribution. While it does not have proprietary drug pipeline programs, it plays a key role in enabling FDA registration and expanding market access for its partners, particularly in the U.S. and Bolivia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KRTL Holding Group.